Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922 · see citing works

α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans

Stefan, N., Hennige, A. M., Staiger, H., Machann, J., Schick, F., Kröber, S. M., Machicao, F. E., Fritsche, A., & Häring, H. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1938 · Cited by 475 · see citing works

Plasma fetuin-A levels and the risk of type 2 diabetes

Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Häring, H.-U., & Schulze, M. B. (2008) · Diabetes · doi:10.2337/db08-0538 · Cited by 379 · see citing works

Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke

Weikert, C., Stefan, N., Schulze, M. B., Pischon, T., Berger, K., Joost, H., Häring, H., Boeing, H., & Fritsche, A. (2008) · Circulation · doi:10.1161/circulationaha.108.814418 · Cited by 310 · see citing works

Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production

Hennige, A. M., Staiger, H., Wicke, C., Machicao, F., Fritsche, A., Häring, H.-U., & Stefan, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001765 · Cited by 282 · see citing works

The Metabolically Benign and Malignant Fatty Liver

Stefan, N., & Häring, H. (2011) · Diabetes · doi:10.2337/db11-0231 · Cited by 172 · see citing works

Fetuin-A: the missing link in lipid-induced inflammation

Heinrichsdorff, J., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2869 · Cited by 76 · see citing works

Fetuin-A (α2HS-Glycoprotein) Is a Major Serum Adhesive Protein That Mediates Growth Signaling in Breast Tumor Cells

Sakwe, A. M., Koumangoye, R. B., Goodwin, S. J., & Ochieng, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128926 · Cited by 69 · see citing works

Lack of Fetuin-A (α2-HS-Glycoprotein) Reduces Mammary Tumor Incidence and Prolongs Tumor Latency via the Transforming Growth Factor-β Signaling Pathway in a Mouse Model of Breast Cancer

Guillory, B., Sakwe, A. M., Saria, M., Thompson, P., Adhiambo, C., Koumangoye, R. B., Ballard, B. R., Binhazim, A. A., Cone, C., Jahnen‐Dechent, W., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100177 · Cited by 47 · see citing works

Mechanisms of Insulin Action and Insulin Resistance

Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · see citing works

AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667 · see citing works

Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications

Stefan, N., Häring, H.-U., Hu, F. B., & Schulze, M. B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70062-7 · Cited by 857 · see citing works

Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance

Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631 · see citing works

Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

Mantovani, A., Byrne, C. D., Bonora, E., & Targher, G. (2018) · Diabetes Care · doi:10.2337/dc17-1902 · Cited by 634 · see citing works

The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance

Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615 · see citing works

The impact of insulin resistance on the kidney and vasculature

Artunç, F., Schleicher, E. D., Weigert, C., Fritsche, A., Stefan, N., & Häring, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.145 · Cited by 474 · see citing works

TLR4 at the Crossroads of Nutrients, Gut Microbiota, and Metabolic Inflammation

Velloso, L. A., Folli, F. B., & Saad, M. J. A. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1100 · Cited by 314 · see citing works

The role of hepatokines in NAFLD

Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 282 · see citing works

Cytokines and abnormal glucose and lipid metabolism

Shi, J., Fan, J., Su, Q., & Yang, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00703 · Cited by 282 · see citing works

The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review

Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278 · see citing works

Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism

Meex, R. C., Hoy, A. J., Morris, A., Brown, R. D., Lo, J. C. Y., Burke, M., Goode, R. J. A., Kingwell, B. A., Kraakman, M. J., Febbraio, M. A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.023 · Cited by 255 · see citing works

Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease

Stefan, N., Schick, F., & Häring, H.-U. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1412427 · Cited by 235 · see citing works

Metabolic Inflammation—A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?

Gehrke, N., & Schattenberg, J. M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.020 · Cited by 211 · see citing works

Phenotypes of prediabetes and stratification of cardiometabolic risk

Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208 · see citing works

Adipose tissue and adipocyte dysregulation

Lafontan, M. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.08.002 · Cited by 206 · see citing works

Metabolic implications of pancreatic fat accumulation

Wagner, R. J., Eckstein, S. S., Yamazaki, H., Gerst, F., Machann, J., Jaghutriz, B. A., Schürmann, A., Solimena, M., Singer, S., Königsrainer, A., et al. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00573-3 · Cited by 193 · see citing works

MECHANISMS IN ENDOCRINOLOGY: Are metabolically healthy obese individuals really healthy?

Blüher, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0540 · Cited by 177 · see citing works

Fetuin-A: A novel link between obesity and related complications

Trepanowski, J. F., Mey, J., & Varady, K. A. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.203 · Cited by 161 · see citing works

Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion

Gerst, F., Wagner, R., Kaiser, G., Panse, M., Heni, M., Machann, J., Bongers, M. N., Sartorius, T., Sipos, B., Fend, F., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4385-1 · Cited by 151 · see citing works

New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Zhang, X., Ji, X., Wang, Q., & Li, J. Z. (2017) · Protein & Cell · doi:10.1007/s13238-017-0436-0 · Cited by 131 · see citing works

Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals

Badoud, F., Perreault, M., Zulyniak, M. A., & Mutch, D. M. (2014) · The FASEB Journal · doi:10.1096/fj.14-263913 · Cited by 127 · see citing works

Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial

Stefan, N., Ramsauer, M., Jordan, P., Nowotny, B., Kantartzis, K., Machann, J., Hwang, J., Nowotny, P., KAHL, S., Harreiter, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70170-0 · Cited by 114 · see citing works

Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity

Anjani, K., Lhomme, M., Sokolovska, N., Poitou, C., Aron-Wisnewsky, J., Bouillot, J.-L., Lesnik, P., Bedossa, P., Kontush, A., Clement, K., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.002 · Cited by 106 · see citing works

Metabolically Healthy and Unhealthy Normal Weight and Obesity

Stefan, N. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.301 · Cited by 98 · see citing works

Precision medicine in type 2 diabetes

Prasad, R. B., & Groop, L. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12859 · Cited by 93 · see citing works

Hepatokines and non-alcoholic fatty liver disease

Lebensztejn, D. M., Flisiak-Jackiewicz, M., Białokoz-Kalinowska, I., Bobrus-Chociej, A., & Kowalska, I. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1252 · Cited by 90 · see citing works

The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans

Peter, A., Kovářová, M., Staiger, H., Machann, J., Schick, F., Königsrainer, A., Königsrainer, I., Schleicher, E. D., Fritsche, A., Häring, H., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2017 · Cited by 82 · see citing works

Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies

Stefan, N., Sun, Q., Fritsche, A., Machann, J., Schick, F., Gerst, F., Jeppesen, C., Joost, H., Hu, F. B., Boeing, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092238 · Cited by 80 · see citing works

Implication of hepatokines in metabolic disorders and cardiovascular diseases

Jung, T. W., Yoo, H. J., & Choi, K. M. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.03.002 · Cited by 71 · see citing works

MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes

Coope, A., Torsoni, A. S., & Velloso, L. A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1065 · Cited by 72 · see citing works

Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome

Jialal, I., Devaraj, S., Bettaieb, A., Haj, F. G., & ADAMS-HUET, B. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.814 · Cited by 67 · see citing works

Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle

Jung, T. W., Chung, Y. H., Kim, H., El‐Aty, A. M. A., & Jeong, J. H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.10.014 · Cited by 64 · see citing works

Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis

Guo, V. Y., Cao, B., Cai, C. C., Cheng, K. K. Y., & Cheung, B. M. Y. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1068-9 · Cited by 63 · see citing works

Fetuin A promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity

Shen, X., Yang, L., Yan, S., Zheng, H., Liang, L., Cai, X., & Liao, M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.014 · Cited by 63 · see citing works

Interaction between plasma fetuin‐A and free fatty acids predicts changes in insulin sensitivity in response to long‐term exercise

Lee-Ødegård, S., Norheim, F., Gulseth, H. L., Langleite, T. M., Kolnes, K. J., Tangen, D. S., Stadheim, H. K., Gilfillan, G. D., Holen, T., Birkeland, K. I., et al. (2017) · Physiological Reports · doi:10.14814/phy2.13183 · Cited by 59 · see citing works

A link between hepatic glucose production and peripheral energy metabolism via hepatokines

Abdul-Wahed, A., Gautier‐Stein, A., Casteras, S., Soty, M., Roussel, D., Romestaing, C., Guillou, H., Tourette, J.-A., Plèche, N., Zitoun, C., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.05.005 · Cited by 61 · see citing works

Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells

Siegel-Axel, D. I., Ullrich, S., Stefan, N., Rittig, K., Gerst, F., Klingler, C., Schmidt, U., Schreiner, B., Randrianarisoa, E., Schaller, H., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3177-0 · Cited by 61 · see citing works

Tissue-Specific Differences in the Development of Insulin Resistance in a Mouse Model for Type 1 Diabetes

Jeleník, T., Séquaris, G., Kaul, K., Ouwens, D. M., Esther Phielix, E., Kotzka, J., Knebel, B., Weiß, J., Reinbeck, A. L., Janke, L., et al. (2014) · Diabetes · doi:10.2337/db13-1794 · Cited by 56 · see citing works

Bone marrow lympho-myeloid malfunction in obesity requires precursor cell-autonomous TLR4

Liu, A., Chen, M., Kumar, R. J., Stefanović-Račić, M., O'Doherty, R. M., Ding, Y., Jahnen‐Dechent, W., & Borghesi, L. (2018) · Nature Communications · doi:10.1038/s41467-018-03145-8 · Cited by 57 · see citing works

Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms

Takahashi, H., Kotani, K., Tanaka, K., Egucih, Y., & Anzai, K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00588 · Cited by 55 · see citing works

Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys.

Stefan, N., Artunc, F., Heyne, N., Machann, J., Schleicher, E., & Häring, H. (2016) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfu081 · Cited by 50 · see citing works

Role of exercise-induced hepatokines in metabolic disorders

Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54 · see citing works

Vitamin B2 deficiency enhances the pro-inflammatory activity of adipocyte, consequences for insulin resistance and metabolic syndrome development

Mazur-Biały, A. I., & Pocheć, E. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.04.010 · Cited by 55 · see citing works

Novel phenotypes of prediabetes?

Häring, H. (2016) · Diabetologia · doi:10.1007/s00125-016-4015-3 · Cited by 53 · see citing works

Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers

Mantovani, A., Lonardo, A., Stefan, N., & Targher, G. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156014 · Cited by 52 · see citing works

The Human Colostrum Whey Proteome Is Altered in Gestational Diabetes Mellitus

Grapov, D., Lemay, D. G., Weber, D., Phinney, B. S., Chertok, I. R. A., Gho, D. S., German, J. B., & Smilowitz, J. T. (2014) · Journal of Proteome Research · doi:10.1021/pr500818d · Cited by 48 · see citing works

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism

Kim, T. H., Hong, D.-G., & Yang, Y. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121903 · Cited by 52 · see citing works

The association between regional adiposity, cognitive function, and dementia-related brain changes: a systematic review

Boccara, E., Golan, S., & Beeri, M. S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1160426 · Cited by 45 · see citing works

Pancreatic steatosis and metabolic pancreatic disease: a new entity?

Caldart, F., de Pretis, N., Luchini, C., Ciccocioppo, R., & Frulloni, L. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03364-y · Cited by 45 · see citing works

Fetuin-A downregulates adiponectin through Wnt-PPARγ pathway in lipid induced inflamed adipocyte

Agarwal, S., Chattopadhyay, M., Mukherjee, S., Dasgupta, S., Mukhopadhyay, S., & Bhattacharya, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.002 · Cited by 42 · see citing works

Palmitate induced Fetuin-A secretion from pancreatic β-cells adversely affects its function and elicits inflammation

Mukhuty, A., Fouzder, C., Mukherjee, S., Malick, C., Mukhopadhyay, S., Bhattacharya, S., & Kundu, R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.022 · Cited by 42 · see citing works

Impairment of energy sensors, SIRT1 and AMPK, in lipid induced inflamed adipocyte is regulated by Fetuin A

Chattopadhyay, M., Mukherjee, S., Chatterjee, S. K., Chattopadhyay, D., Das, S., Majumdar, S. S., Mukhopadhyay, S., Mukherjee, S., & Bhattarcharya, S. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.10.005 · Cited by 42 · see citing works

Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses

Li, Z., Lin, M., Liu, C., Wang, D., Shi, X., Zheng, C., Liu, Y., Yang, S., & Li, X. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.023 · Cited by 43 · see citing works

A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial

Otten, J., Stomby, A., Waling, M. U., Isaksson, A., Söderström, I., Ryberg, M., Svensson, M., Hauksson, J. B., & Olsson, T. (2018) · Diabetologia · doi:10.1007/s00125-018-4618-y · Cited by 42 · see citing works

Inhibiting CD36 palmitoylation improves cardiac function post-infarction by regulating lipid metabolic homeostasis and autophagy

Zhang, Q.-W., Li, J.-M., Liu, X., Chen, X.-M., Zhu, L.-W., Zhang, Z., Hu, Y.-Y., Zhao, T., Lou, H., Xu, H.-H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61875-y · Cited by 45 · see citing works

Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression

Ochi, A., Mori, K., Emoto, M., Nakatani, S., Morioka, T., Motoyama, K., Fukumoto, S., Imanishi, Y., Koyama, H., Ishimura, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088704 · Cited by 40 · see citing works

Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study

Zhu, J., Wan, X., Wang, Y., Zhu, K.-F., Li, C., Yu, C., & Li, Y. (2016) · Endocrine · doi:10.1007/s12020-016-1112-5 · Cited by 41 · see citing works

Could circulating fetuin A be a biomarker of aortic valve stenosis?

Minno, A. D., Zanobini, M., Myasoedova, V. A., Valerio, V., Songia, P., Saccocci, M., Minno, M. N. D. D., Tremoli, E., & Poggio, P. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.040 · Cited by 40 · see citing works

Behavioral Lifestyle Interventions for Weight Loss in Overweight or Obese Patients with Type 2 Diabetes: A Systematic Review of the Literature

Gostoli, S., Raimondi, G., Popa, A. P., Giovannini, M., Benasi, G., & Rafanelli, C. (2024) · Current Obesity Reports · doi:10.1007/s13679-024-00552-5 · Cited by 46 · see citing works

From infancy to aging: Biological and behavioral modifiers of Fetuin-A

Robinson, K. N., & Terán-Garcı́a, M. (2015) · Biochimie · doi:10.1016/j.biochi.2015.12.016 · Cited by 35 · see citing works

Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation

Miao, X., Alidadipour, A., Saed, V., Sayyadi, F., Jadidi, Y., Davoudi, M., Amraee, F., Jadidi, N., & Afrisham, R. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02335-9 · Cited by 34 · see citing works

Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance

Ren, G., Kim, T., Papizan, J. B., Okerberg, C. K., Kothari, V. M., Zaid, H., Bilan, P. J., Araya-Ramírez, F., Littlefield, L. A., Bowers, R. L., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00089.2018 · Cited by 34 · see citing works

Circulating Fetuin-A and Risk of All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Zhou, Z., Ji, Y., Ju, H., Chen, H., & Sun, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00966 · Cited by 34 · see citing works

Increased serum levels of fetuin B in patients with coronary artery disease

Zhu, K., Wang, Y., Shu, P., Zhou, Q., Zhu, J., Zhou, W., Du, C., Xu, C., Liu, X., & Tang, L. (2017) · Endocrine · doi:10.1007/s12020-017-1387-1 · Cited by 33 · see citing works

Serum levels of fetuin A are increased in women with gestational diabetes mellitus

İyidir, Ö. T., Değertekin, C. K., Yılmaz, B. A., Altınova, A. E., Törüner, F. B., Bozkurt, N., Ayvaz, G., & Aktürk, M. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3490-3 · Cited by 32 · see citing works

Infections at the nexus of metabolic-associated fatty liver disease

Boeckmans, J., Rombaut, M., Demuyser, T., Declerck, B., Piérard, D., Rogiers, V., Kock, J. D., Waumans, L., Magerman, K., Cartuyvels, R., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03069-1 · Cited by 32 · see citing works

The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A

Wagner, R. J., Machann, J., Guthoff, M., Nawroth, P. P., Nadalin, S., Saleem, M. A., Heyne, N., Königsrainer, A., Fend, F., Schick, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02210-4 · Cited by 32 · see citing works

The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells

Gerst, F., Kemter, E., Lorza‐Gil, E., Kaiser, G., Fritz, A.-K., Nano, R., Piemonti, L., Gauder, M., Dahl, A., Nadalin, S., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05435-1 · Cited by 31 · see citing works

Adipose-derived extracellular vesicles – a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome

Mladenović, D. R., Vesković, M. N., Šutulović, N., Hrnčić, D., Stanojlović, O. P., Radić, L., Macut, J. B., & Μacut, D. (2024) · Endocrine · doi:10.1007/s12020-024-03702-w · Cited by 30 · see citing works

Fetuin-A and risk of diabetes-related vascular complications: a prospective study

Birukov, A., Polemiti, E., Jäger, S., Stefan, N., & Schulze, M. B. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01439-8 · Cited by 31 · see citing works

NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status

Kim, Y., Chang, Y., Ryu, S., Wild, S. H., & Byrne, C. D. (2022) · Hepatology · doi:10.1002/hep.32560 · Cited by 29 · see citing works

Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis

Sujana, C., Huth, C., Zierer, A., Meesters, S., Sudduth-Klinger, J., Köenig, W., Herder, C., Peters, A., & Thorand, B. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1053 · Cited by 30 · see citing works

Liver fat as risk factor of hepatic and cardiometabolic diseases

Demir, M., Bornstein, S. R., Mantzoros, C. S., & Perakakis, N. (2023) · Obesity Reviews · doi:10.1111/obr.13612 · Cited by 29 · see citing works

An extended fatty liver index to predict non-alcoholic fatty liver disease

Kantartzis, K., Rettig, I., Staiger, H., Machann, J., Schick, F., Scheja, L., Gastaldelli, A., Bugianesi, E., Peter, A., Schulze, M. B., et al. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.11.006 · Cited by 27 · see citing works

Serum fetuin‐B is positively associated with intrahepatic triglyceride content and increases the risk of insulin resistance in obese Chinese adults: A cross‐sectional study

Wang, D., Liu, Y., Liu, S., Lin, L., Liu, C., Shi, X., Chen, Z., Lin, M., Yang, S., Li, Z., et al. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12632 · Cited by 27 · see citing works

Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease

Liu, S., Xiao, J., Zhao, Z., Wang, M., Wang, Y., & Xin, Y. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00081 · Cited by 28 · see citing works

Causal relationship between body mass index and fetuin‐ A level in the asian population: a bidirectional mendelian randomization study

Thakkinstian, A., Chailurkit, L., Warodomwichit, D., Ratanachaiwong, W., Yamwong, S., Chanprasertyothin, S., Attia, J., Sritara, P., & Ongphiphadhanakul, B. (2013) · Clinical Endocrinology · doi:10.1111/cen.12303 · Cited by 25 · see citing works

Effects of nutritional status on serum fetuin-A level

İçer, M. A., & Yıldıran, H. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1631751 · Cited by 27 · see citing works

Dyslipidemia and aging: the non-linear association between atherogenic index of plasma (AIP) and aging acceleration

Yang, Q., Zhu, X., Zhang, L., & Luo, F. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02695-8 · Cited by 23 · see citing works

High free fatty acid levels are associated with stroke recurrence and poor functional outcome in Chinese patients with ischemic stroke

Niu, Z., Hu, H., & Tang, F. (2016) · The journal of nutrition health & aging · doi:10.1007/s12603-016-0852-5 · Cited by 23 · see citing works

Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis

Kröger, J., Meidtner, K., Stefan, N., Guevara, M., Kerrison, N. D., Ardanáz, E., Aune, D., Boeing, H., Dorronsoro, M., Dow, C., et al. (2018) · Diabetes · doi:10.2337/db17-1268 · Cited by 23 · see citing works

Loss of pigment epithelium-derived factor leads to ovarian oxidative damage accompanied by diminished ovarian reserve in mice

Li, X., Wang, H., Tan, J. H., Wu, Y., Yang, M. W. O., Mao, C., Gao, S., Li, H., Chen, H., & Cai, W. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.11.015 · Cited by 22 · see citing works

Organokines and Exosomes: Integrators of Adipose Tissue Macrophage Polarization and Recruitment in Obesity

Wang, Y. Y., Wang, Y., Qi, X.-Y., Liao, Z., Mai, Y.-N., & Xiao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839849 · Cited by 22 · see citing works

Fetuin-A: A negative acute-phase protein linked to adipose tissue function in periparturient dairy cows

Strieder‐Barboza, C., de Souza, J., Raphael, W., Lock, A. L., & Contreras, G. A. (2017) · Journal of Dairy Science · doi:10.3168/jds.2017-13644 · Cited by 22 · see citing works

Plasma Fetuin-A Levels and Risk of Type 2 Diabetes Mellitus in A Chinese Population: A Nested Case-Control Study

Wang, Y., Koh, W., Jensen, M. K., Yuan, J., & Pan, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0171 · Cited by 20 · see citing works

Elevated Serum and Cerebrospinal Fluid Free Fatty Acid Levels Are Associated with Unfavorable Functional Outcome in Subjects with Acute Ischemic Stroke

Duan, X., Zhang, G.-P., Wang, X.-B., Yu, H., Wu, J., Liu, K., Wang, L., & Long, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9756-y · Cited by 20 · see citing works

Raised Circulating Fetuin-A After 28-Day Overfeeding in Healthy Humans

Samocha‐Bonet, D., Tam, C. S., Campbell, L. V., & Heilbronn, L. K. (2013) · Diabetes Care · doi:10.2337/dc13-1728 · Cited by 19 · see citing works

Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano‐energetic efficiency

Fiorentino, T. V., Miceli, S., Succurro, E., Sciacqua, A., Andreozzi, F., & Sesti, G. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13155 · Cited by 19 · see citing works

Effects of Hyperthyroidism on Adipose Tissue Activity and Distribution in Adults

Steinhoff, K. G., Krause, K., Linder, N., Rullmann, M., Volke, L., Gebhardt, C., Busse, H., Stümvoll, M., Blüher, M., Sabri, O., et al. (2020) · Thyroid · doi:10.1089/thy.2019.0806 · Cited by 19 · see citing works

Fetuin-A and its genetic association with cardiometabolic disease

Ali, L. A., van de Vegte, Y. J., Said, M. A., Groot, H. E., Hendriks, T., Yeung, M. W., Lipšic, E., & van der Harst, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-48600-9 · Cited by 19 · see citing works

Fetuin B aggravates liver X receptor-mediated hepatic steatosis through AMPK in HepG2 cells and mice.

Zhou, W., Yang, J. H., Zhu, J., Wang, Y., Wu, Y., Xu, L., & Yang, Y. (2019) · Europe PMC (PubMed Central) · Cited by 19 · see citing works

Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium

Jensen, M. K., Jensen, R. A., Mukamal, K. J., Guo, X., Yao, J., Sun, Q., Cornelis, M. C., Liu, Y., Chen, M., Kizer, J. R., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx091 · Cited by 18 · see citing works

Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus

Zhou, Z., Ju, H., Sun, M., Chen, H., Fu, Q.-P., & Jiang, D. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.023 · Cited by 19 · see citing works

Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity

Stienstra, R., & Stefan, N. (2013) · Diabetologia · doi:10.1007/s00125-013-3040-8 · Cited by 17 · see citing works

Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease

Huang, Y. F., Huang, X., Ding, L., Po, W., Peng, K., Chen, Y., Dai, M., Zhang, D., Xu, M., Bi, Y., et al. (2015) · Medicine · doi:10.1097/md.0000000000001517 · Cited by 17 · see citing works

Serum free fatty acids are associated with severe coronary artery calcification, especially in diabetes: a retrospective study

Xin, Y., Zhang, J., Fan, Y., & Wang, C. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02152-w · Cited by 16 · see citing works

Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study

Giannouli, A., Stefanaki, C., Kouskoutis, C., Konidari, M., Mani, I., Konidari, K., Markantonis, S. L., Mantzou, A., Dourakis, S. P., Deligeoroglou, E., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175744 · Cited by 15 · see citing works

Effect of moderate alcohol consumption on fetuin-A levels in men and women: post-hoc analyses of three open-label randomized crossover trials

Joosten, M. M., Schrieks, I. C., & Hendriks, H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-24 · Cited by 12 · see citing works

Association of Human Fetuin-A rs4917 Polymorphism with Obesity in 2 Cohorts

Temesszentandrási, G., Vörös, K., Böröcz, Z., Kaszás, E., Prohászka, Z., Falus, A., Cseh, K., & Kalabay, L. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000151 · Cited by 12 · see citing works

Association of fetuin-A with dyslipidemia and insulin resistance in type-II Diabetics of Pakistani population

Fatima, F., Ahsan, N., Nasim, A., & Alam, F. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.2.1106 · Cited by 19 · see citing works

Fetuin-A mediates the difference in adipose tissue insulin resistance between young adult pakistani and norwegian patients with type 2 diabetes

Lee-Ødegård, S., Ueland, T., Thorsby, P. M., Aukrust, P., Michelsen, A. E., Halvorsen, B. L., Drevon, C. A., & Birkeland, K. I. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01127-y · Cited by 13 · see citing works

Raised Circulating Fetuin-A After 28-Day Overfeeding in Healthy Humans

Samocha‐Bonet, D., Tam, C. S., Campbell, L. V., & Heilbronn, L. K. (2013) · Diabetes Care · doi:10.2337/dc13-1728 · Cited by 19 · see citing works

Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults

Song, A., Xu, M., Bi, Y., Xu, Y., Huang, Y., Li, M., Wang, T., Wu, Y., Liu, Y., Li, X., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019228 · Cited by 84 · see citing works

[Insulin resistance and free fatty acid].

Shimabukuro, M. (2012) · PubMed · Cited by 1 · see citing works